The goal of this work was to nondestructively measure glomerular (and thereby nephron) number in the whole kidney. Variations in the number and size of glomeruli have been linked to many renal and systemic diseases. Here, we develop a robust magnetic resonance imaging (MRI) technique based on injection of cationic ferritin (CF) to produce an accurate measurement of number and size of individual glomeruli. High-field (19 Tesla) gradient-echo MR images of perfused rat kidneys after in vivo intravenous injection of CF showed specific labeling of individual glomeruli with CF throughout the kidney. We developed a three-dimensional image-processing algorithm to count every labeled glomerulus. MRI-based counts yielded 33,786 Ϯ 3,753 labeled glomeruli (n ϭ 5 kidneys). Acid maceration counting of contralateral kidneys yielded an estimate of 30,585 Ϯ 2,053 glomeruli (n ϭ 6 kidneys). Disector/fractionator stereology counting yielded an estimate of 34,963 glomeruli (n ϭ 2). MRI-based measurement of apparent glomerular volume of labeled glomeruli was 4.89 ϫ 10 Ϫ4 mm 3 (n ϭ 5) compared with the average stereological measurement of 4.99 ϫ 10 Ϫ4 mm 3 (n ϭ 2). The MRI-based technique also yielded the intrarenal distribution of apparent glomerular volume, a measurement previously unobtainable in histology. This work makes it possible to nondestructively measure whole-kidney glomerular number and apparent glomerular volumes to study susceptibility to renal diseases and opens the door to similar in vivo measurements in animals and humans. stereology; nephron; glomerulus count; nanoparticles; magnetic resonance imaging THE PURPOSE OF THIS WORK WAS to measure the number and size of all glomeruli in the entire, intact kidney using magnetic resonance imaging (MRI). Changes in the number and size of glomeruli have been linked to a number of renal and systemic diseases (5, 7). However, current techniques for counting and measuring glomeruli, such as acid maceration (4) and the dissector/fractionator stereology technique (3), require the destruction of the entire kidney. Furthermore, conventional histological techniques extrapolate the total number and size of glomeruli from a selected number of histological sections or isolated glomeruli. Current techniques are thus estimates rather than direct measurements and do not allow for localization of identified functioning glomeruli to specific parts of the kidney. A method for directly and nondestructively measuring the number and size of all glomeruli in the kidney would serve as a useful tool in animal studies and potentially in the clinic.
Here, we develop a robust magnetic resonance imaging (MRI) technique based on injection of cationic ferritin (CF) to produce an accurate measurement of number and size of individual glomeruli. High-field (19 Tesla) gradient-echo MR images of perfused rat kidneys after in vivo intravenous injection of CF showed specific labeling of individual glomeruli with CF throughout the kidney. We developed a three-dimensional image-processing algorithm to count every labeled glomerulus. MRI-based counts yielded 33,786 Ϯ 3,753 labeled glomeruli (n ϭ 5 kidneys). Acid maceration counting of contralateral kidneys yielded an estimate of 30,585 Ϯ 2,053 glomeruli (n ϭ 6 kidneys). Disector/fractionator stereology counting yielded an estimate of 34,963 glomeruli (n ϭ 2). MRI-based measurement of apparent glomerular volume of labeled glomeruli was 4.89 ϫ 10 Ϫ4 mm 3 (n ϭ 5) compared with the average stereological measurement of 4.99 ϫ 10 Ϫ4 mm 3 (n ϭ 2). The MRI-based technique also yielded the intrarenal distribution of apparent glomerular volume, a measurement previously unobtainable in histology. This work makes it possible to nondestructively measure whole-kidney glomerular number and apparent glomerular volumes to study susceptibility to renal diseases and opens the door to similar in vivo measurements in animals and humans. stereology; nephron; glomerulus count; nanoparticles; magnetic resonance imaging THE PURPOSE OF THIS WORK WAS to measure the number and size of all glomeruli in the entire, intact kidney using magnetic resonance imaging (MRI). Changes in the number and size of glomeruli have been linked to a number of renal and systemic diseases (5, 7). However, current techniques for counting and measuring glomeruli, such as acid maceration (4) and the dissector/fractionator stereology technique (3), require the destruction of the entire kidney. Furthermore, conventional histological techniques extrapolate the total number and size of glomeruli from a selected number of histological sections or isolated glomeruli. Current techniques are thus estimates rather than direct measurements and do not allow for localization of identified functioning glomeruli to specific parts of the kidney. A method for directly and nondestructively measuring the number and size of all glomeruli in the kidney would serve as a useful tool in animal studies and potentially in the clinic.
Recently we demonstrated that intravenous injections of the iron-binding protein ferritin, functionalized with cationic amine groups (6), can be used to detect individual glomeruli both in vivo and ex vivo with MRI (1). This method is based on the electrostatic binding of cationic ferritin (CF) to the anionic macromolecules of the glomerular basement membrane (GBM) and subsequent perturbation of the magnetic field around the labeled GBM by ferritin, resulting in a decrease in the MRI signal at the location of the glomerulus. Here, we develop and validate the technique of systemic injection of cationic ferritin (CF) to count individual glomeruli and measure individual glomerular size with three-dimensional (3D) MRI. We demonstrate that glomerular counts obtained from 3D MRI volumes are consistent with counts obtained with established histological methods, with the advantage of retaining the intact kidney.
MATERIALS AND METHODS
In vitro preparation and imaging. CF was synthesized by conjugating horse spleen ferritin (Sigma-Aldrich, St. Louis, MO) to N,Ndimethyl-1,3-propanediamine (DMPA) using 1-ethyl-3(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC), according to Danon et al. (6) . Male Sprague-Dawley rats, weighing between 215 and 245 g, were given three intravenous bolus doses (11 mg/ml in phosphate buffered saline at pH 7.2) of 5.75 mg/100 g of CF (n ϭ 6) or native ferritin (NF; n ϭ 6) with 1.5 h between injections. Kidneys were perfused and fixed via transcardial perfusion of PBS followed by 10% neutral buffered formalin, then resected and stored in glutaraldehyde. All experiments involving animals were carried out according to a protocol approved by the Arizona State University Institutional Animal Care and Use Committee. The perfused left kidneys were imaged in glutaraldehyde on a Varian 19T 89-mm-bore NMR (Varian, Palo Alto, CA), equipped with a DOTY 3-axis imaging probe and a gradient with a maximum strength of 300 G/cm (DOTY Scientific, Columbia, SC). Scans were acquired with a 3D gradient echo (GRE) sequence with echo time/repetition time ϭ 7/40 ms and a resolution of 62 ϫ 62 ϫ 78 m. Total scan time was 6 h/kidney.
Postprocessing. Labeled glomeruli in the 3D MRI data set were counted using custom software written in Matlab (The Mathworks, Natick, MA). A bicubic interpolation method was used to resize the 3D MRI data sets and change the spatial resolution to 31 ϫ 31 ϫ 62 m. Spatial signal magnitude gradients were then calculated to extract any dramatic spatial changes in signal magnitude throughout the volume. Voxels exceeding a signal magnitude difference of 0.11, on a signal magnitude scale of 0 -1, defined regions to be included in the following operations. Regional minima were located in these areas using an upper signal magnitude threshold of 0.4, based on a signal magnitude scale of 0 -1. Regions considered to be glomeruli were then defined based on morphological thresholds, assuming that a glomer-ulus is approximately spherical. A watershed transform was computed on these regions to distinguish individual glomeruli where signal overlap of multiple glomeruli might occur (2, 8, 9) .
MRI-based apparent glomerular volume measurements were made based on the number of voxels per glomerulus isolated by the counting algorithm multiplied by the postinterpolation voxel dimensions (31 ϫ 31 ϫ 62 m). A superior threshold of 64 voxels/ glomerulus (38 ϫ 10 Ϫ4 mm 3 or a glomerular diameter of 194 m) was set to eliminate possible "false" glomeruli. Glomeruli containing Ͻ64 voxels were included in the results. We have defined glomerular volumes measured using the MRI-based technique as "apparent glomerular volume" because the relationship between the amount of CF accumulated in the GBM and the volume of susceptibility is yet unresolved in this system.
Histology. We performed two techniques to validate the MRI-based measurements of glomeruli: 1) acid maceration and counting and 2) stereology. Acid maceration was based on techniques established in the literature (4) . Briefly, kidneys were cut into 1-mm 3 pieces immediately after resection and incubated in 5 ml of 6 N HCl for 1.5 h. Incubated tissue was crushed and strained until homogenous. The solution was then brought up to 30 ml with deionized water. Glomeruli in solution were counted in a counting chamber (1-mm 2 scored 35-mm culture dish, Nunclon ⌬; Nalgene Labware, Rochester, NY). The total number of glomeruli in each kidney was calculated based on the average number of glomeruli per area.
Stereology was performed on two kidneys. Serial sections of the left (imaged) kidneys were sampled, and individual glomeruli across serial sections were compared and measured using the physical dissector/fractionator method as previously described (3).
Statistics. All statistical analyses comparing the MRI and acid maceration or stereological measurements from each respective animal were run as paired two-tailed Student's t-tests to test the null hypothesis that the mean difference between pairs is zero at the significance level ␣ ϭ 0.05 (The Mathworks).
RESULTS
Excised, perfused kidneys were imaged after systemic CF or native ferritin (NF) injections. T 2* -weighted 3D gradient echo MR images of the kidneys showed a dark MRI signal at the location of glomeruli after CF injections, but not after NF injections. The specific binding of CF, but not NF, was previously confirmed with immunofluorescence and electron microscopy (1) . Figure 1 shows the results of an automated 3D segmentation algorithm to identify individual glomeruli. In the figure, identified glomeruli are arbitrarily colored in axial slices of the 3D images of perfused, excised kidneys of CF-injected rats (Fig.  1B) . Counting of CF-labeled glomeruli from 3D MRI data sets yielded 33,786 Ϯ 3,753 glomeruli (n ϭ 5). One kidney was removed from group analyses as an outlier due to erratic stereological and imaging measurements ( Table 1 ). The same counting algorithm yielded 1,916 Ϯ 806 nephrons from 3D MRI data sets of kidneys from NF-injected rats (n ϭ 6). Acid maceration counting of contralateral kidneys from CF-injected rats yielded 30,585 Ϯ 2,053 glomeruli (n ϭ 6). The dissector/ Fig. 1 . Whole-kidney identification of individual glomeruli. A representative axial kidney image from a 3-dimensional (3D) magnetic resonance imaging (MRI) data set from a cationic ferritin (CF)-injected animal is shown (A). The data were analyzed with a 3D counting algorithm to identify glomeruli. Regions defined as glomeruli by the computational 3D counting algorithm were assigned an arbitrary color exclusively for visualization purposes (B). One kidney was removed from group analyses (labeled "outlier") due to erratic stereological and imaging measurements. MRI, magnetic resonance imaging. Measurements of intrarenal SD in apparent glomerular volumes are unique to the MRI-based glomerular counting technique. Vglom, mean glomerular volume; Av IVglom, the average apparent glomerular volume of all individual glomeruli in a kidney; IVglom SD, the SD of apparent glomerular volumes of all glomeruli in a kidney; SD, ϮSD.
fractionator stereology yielded counts of 35,421 and 34,504 glomeruli compared with MRI-based counts in the same kidneys of 32,789 and 35,203 glomeruli, respectively. Paired two-tailed Student's t-tests to test the null hypothesis that the mean difference between pairs is zero showed that there were no significant differences between glomerular counts from the MRI-based method and from the acid maceration or stereological methods (at the significance level ␣ ϭ 0.05). Counting results of all CF-injected rats are reported in Table 1 . False positives counted in the control kidneys indicate a counting error of ϳ2,000 extra glomeruli/kidney, or ϳ5.5% error.
Individual apparent glomerular volumes were calculated based on the number of voxels per individual glomerulus and the voxel dimensions. Apparent volume measurements of labeled glomeruli using the MRI-based technique yielded 4.89 ϫ 10 Ϫ4 mm 3 (n ϭ 5), compared with stereological volume measurements of 4.99 ϫ 10 Ϫ4 mm 3 (n ϭ 2). Using the MRI-based technique, we were also able to calculate the intrarenal SD of apparent glomerular volumes. This measurement is not obtained by stereology because the average glomerular volume measured using stereology is based on the extrapolated total volume of glomeruli divided by the extrapolated total number of glomeruli per kidney. Glomerular volumes are reported in Table 1 , and volume distributions are shown as a histogram in Fig. 2 .
DISCUSSION
In this work, we have developed a nondestructive method for measuring glomerular number based on the accumulation of CF in the GBM. There were insignificant systematic differences between MRI-based measurements and measurements obtained with acid maceration and stereology. MRI-based counts yielded slightly more glomeruli than acid maceration and slightly fewer than stereology. Overcounting is due to the identification of nonglomerular regions that are of similar signal magnitude and shape of glomeruli. This error is observed in the measurement of ϳ2,000 glomeruli/kidney in unlabeled kidneys.
We note that both of the established techniques for counting glomeruli, and thereby nephrons, are based on extrapolations of a limited number of counts to the entire kidney, while the MRI-based technique counts all glomeruli in the entire kidney. The MRI-based technique is advantageous for measuring glomerular volume because the volume of each labeled glomerulus in the entire kidney is measured and recorded. The intrarenal distribution of apparent glomerular volumes is a potentially new parameter for investigation.
While our average apparent glomerular volume measurements compare well with the volumes measured using stereology, care should be taken when one interprets glomerular volumes measured using MRI and superparamagnetic agents such as CF, as the volume of magnetic susceptibility may depend on the amount and the manner in which the agent accumulates in the GBM. Thus we have defined the MRI-based glomerular volume measurements as "apparent glomerular volume." The strong correlation between MRI-based measurements of apparent glomerular volume and those from stereology suggests that the fringe field of the accumulated CF does not extend beyond the glomerulus. It is likely that larger superparamagnetic particles of higher relaxivity would not be suitable for such measurements due to a larger fringe field.
The magnetic field strength of the MRI scanner should also be taken into consideration when these measurements are made. While we have seen adequate labeling of glomeruli with a 5.75 mg/100 g dose of CF at 7 Tesla (data not shown), it should be noted that the effects of CF accumulation on the signal decrease with lowered field strength. This means that greater doses of CF or particles of higher relaxivity may be required for visualization of glomeruli at fields Ͻ7 Tesla. Magnets of lower field strength may achieve the same spatial resolution, although this may require improved radio frequency (RF) probes built specifically for kidney imaging. Conversely, magnets of higher field strength have their own unique challenges, including B 1 inhomogeneities. While unnecessary in the present study due to the small size of the kidneys imaged, corrections to the B 1 field and RF coils may be required to image larger kidneys at high fields.
One potential complication of MRI-based counting is the possibility that CF labels only functioning glomeruli, or that labeling of glomeruli may be affected by disease. Indeed, our recent work demonstrated that CF labeling of the GBM is affected by early-and late-stage puromycin-induced glomerulosclerosis (1). These effects may be focal or global, depending on the nature of the disease. Care must be taken to establish the effectiveness of MRI-based counts in any animal disease model. In addition, while MRI is faster and less labor intensive than stereological techniques, it requires both clean anatomic perfusion to avoid MRI artifacts from blood in the excised kidney as well as significant expertise in scanner operation. There is room for significant improvements in MRI acquisition strategies to reduce sensitivity to artifacts and shorten scan times via improvements in pulse sequence and acquisition design.
While this work is focused on labeling and measuring glomeruli ex vivo, this is a first step in establishing wholekidney nephron measurements in vivo. We have shown in previous work (1) that labeled glomeruli may be detected in vivo using the same labeling and MRI techniques. Future work will be focused on establishing the optimum dose of CF required to detect individual glomeruli in vivo and overcoming partial volume effects due to decreased resolution to achieve reasonable in vivo scan times. Furthermore, thorough in vivo toxicity screens of CF will be required if this technique is to be used as a tool to assess of renal health. Initial toxicology suggests that intravenously delivered CF is not acutely toxic, although these studies are ongoing. Nonetheless, in vivo measurements of nephron number and single glomerular function could be important for longitudinal studies of focal and segmental renal diseases and to monitor the progress of therapy.
We conclude that the MRI-based technique is capable of measuring the number and apparent size of individual glomeruli in 3D and yields comparable results to established methods. This result, along with previous in vivo detection of glomeruli with MRI, suggests the possibility of measuring glomeruli in living animals and in the clinic. To the best of our knowledge, this is the first report of a technique to nondestructively count and measure every glomerulus in the whole kidney.
